144 related articles for article (PubMed ID: 31319393)
41. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
[TBL] [Abstract][Full Text] [Related]
42. Correlation between cancer antigen 15.3 value and qualitative and semiquantitative parameters of positron emission tomography/computed tomography in breast cancer patients.
Cervino AR; Saibene T; Michieletto S; Ghiotto C; Bozza F; Saladini G; Evangelista L
Curr Radiopharm; 2014; 7(1):20-8. PubMed ID: 24836946
[TBL] [Abstract][Full Text] [Related]
43. Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer?
Simos D; Hutton B; Clemons M
J Oncol Pract; 2015 Jan; 11(1):62-8. PubMed ID: 25392522
[TBL] [Abstract][Full Text] [Related]
44. The diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis.
Dong Y; Hou H; Wang C; Li J; Yao Q; Amer S; Tian M
Biomed Res Int; 2015; 2015():489021. PubMed ID: 25879025
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
[TBL] [Abstract][Full Text] [Related]
46. The role of FDG-PET/CT in suspected recurrence of breast cancer.
Radan L; Ben-Haim S; Bar-Shalom R; Guralnik L; Israel O
Cancer; 2006 Dec; 107(11):2545-51. PubMed ID: 17063499
[TBL] [Abstract][Full Text] [Related]
47. Downstream Breast Imaging Following Screening Mammography in Medicare Patients with Advanced Cancer: A Population-Based Study.
Sadigh G; Duszak R; Ward KC; Jiang R; Switchenko JM; Applegate KE; Carlos RC
J Gen Intern Med; 2018 Mar; 33(3):284-290. PubMed ID: 29139055
[TBL] [Abstract][Full Text] [Related]
48. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
[TBL] [Abstract][Full Text] [Related]
49. The Use of Breast Magnetic Resonance Imaging Parameters to Identify Possible Signaling Pathways of a Serum Biomarker, HE4.
Durur-Karakaya A; Durur-Subasi I; Karaman A; Akcay MN; Palabiyik SS; Erdemci B; Alper F; Acemoglu H
J Comput Assist Tomogr; 2016; 40(3):436-41. PubMed ID: 27192502
[TBL] [Abstract][Full Text] [Related]
50. Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely (®) Initiative.
Landercasper J; Bailey L; Berry TS; Buras RR; Degnim AC; Fayanju OM; Froman J; Gass J; Greenberg C; Mautner SK; Krontiras H; Rao R; Sowden M; Tjoe JA; Wexelman B; Wilke L; Chen SL
Ann Surg Oncol; 2016 Oct; 23(10):3112-8. PubMed ID: 27334216
[TBL] [Abstract][Full Text] [Related]
51. Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer.
Loggers ET; Buist DS; Gold LS; Zeliadt S; Hunter Merrill R; Etzioni R; Ramsey SD; Sullivan SD; Kessler L
Int J Breast Cancer; 2016; 2016():2182985. PubMed ID: 27525122
[TBL] [Abstract][Full Text] [Related]
52. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer.
Henderson LM; Ichikawa L; Buist DSM; Lee JM; Bush M; Johnson D; Onega T; Nekhlyudov L; Kerlikowske K; Miglioretti DL; Sprague BL; Wernli KJ
J Gen Intern Med; 2019 Oct; 34(10):2098-2106. PubMed ID: 31410813
[TBL] [Abstract][Full Text] [Related]
53. Early Trends Among Seven Recommendations From the Choosing Wisely Campaign.
Rosenberg A; Agiro A; Gottlieb M; Barron J; Brady P; Liu Y; Li C; DeVries A
JAMA Intern Med; 2015 Dec; 175(12):1913-20. PubMed ID: 26457643
[TBL] [Abstract][Full Text] [Related]
54. Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016.
Lowry KP; Callaway KA; Lee JM; Zhang F; Ross-Degnan D; Wharam JF; Kerlikowske K; Wernli KJ; Kurian AW; Henderson LM; Stout NK
J Natl Compr Canc Netw; 2022 Apr; 20(4):379-386.e9. PubMed ID: 35390766
[TBL] [Abstract][Full Text] [Related]
55. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
Balekian AA; Fisher JM; Gould MK
Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
[TBL] [Abstract][Full Text] [Related]
56. Limiting surveillance imaging for patients with lymphoma in remission: a mixed methods study leading to a Choosing Wisely recommendation.
Paltiel O; Raviv Sharabi G; Tzemach R; Rechavi T; Trachtenberg E; Goldschmidt N; Dann EJ; Bar-Shalom R
BMJ Qual Saf; 2021 Apr; 30(4):300-310. PubMed ID: 32467340
[TBL] [Abstract][Full Text] [Related]
57. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.
Ko NY; Hong S; Winn RA; Calip GS
JAMA Oncol; 2020 Mar; 6(3):385-392. PubMed ID: 31917398
[TBL] [Abstract][Full Text] [Related]
58. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors.
Ruddy KJ; Sangaralingham L; Freedman RA; Mougalian SS; Neuman H; Greenberg C; Jemal A; Duma N; Haddad TC; Lemaine V; Ghosh K; Hieken TJ; Hunt K; Vachon C; Gross CP; Shah ND
J Natl Compr Canc Netw; 2018 May; 16(5):526-534. PubMed ID: 29752327
[No Abstract] [Full Text] [Related]
59. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
[No Abstract] [Full Text] [Related]
60. Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?
Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares Á; Vázquez-Caruncho M
Eur Radiol; 2020 Jan; 30(1):514-522. PubMed ID: 31375867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
